The Army will use physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist.
The only approved gene therapy for RP today targets a single gene RPE65, which accounts for just 1% to 2% of the total RP patient population. We believe OCU400 has significantly wider commercial ...
Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...
With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
Dr. Kelley adds two decades of highly relevant drug development and regulatory strategy experience spanning oncology, rare diseases and CNSNewly formed executive team is committed to execution and ...
If you are looking to continue your career in defense and systems, engineering, supply chain, operations, and technology, GE ...
On Thursday night, Hosanna House rounded out Black History Month with a program emceed by Pittsburgh’s Action News 4’s very ...
Q4 2025 Management View CEO Nello Mainolfi reflected on 2025 as "truly a breakout year" for Kymera, highlighting the progress of the first-in-class STAT6 degrader program. Mainolfi stated, "We shared ...
Chief Executive Officer — Harout Semerjian Chief Commercial Officer — Ahmed ElNawawi Executive Vice President, Research and Development and Chief Medical Officer — Joseph Eid Chief Financial Officer — ...
ArcBest will donate $750,000 to the U.S. Marshals Museum and the Fort Kids Children's Museum in Fort Smith, the company said ...
The Peoria Housing Authority Board of Commissioners announced Monday that it has terminated the employment of its chief financial officer following the discovery of financial irregularities in the ...
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer ...